A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism
- PMID: 512846
- DOI: 10.1007/BF01062538
A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism
Abstract
A combined perfusion/compartmental pharmacokinetic model has been developed to describe the time course of drugs that are subject to preabsorptive, intestinal epithelial, and hepatic first-pass metabolism. Equations are derived to estimate the fraction of the administered dose which is metabolized at each of the three sites and to establish the limits of the true absorption rate constant. The model is tested using literature data for phenacetin.
Similar articles
-
Pharmacokinetic model of presystemic metabolism.Drug Metab Dispos. 1978 Mar-Apr;6(2):193-6. Drug Metab Dispos. 1978. PMID: 26536
-
Prediction of intestinal first-pass drug metabolism.Curr Drug Metab. 2007 Oct;8(7):676-84. doi: 10.2174/138920007782109733. Curr Drug Metab. 2007. PMID: 17979655 Review.
-
Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.Drug Metab Dispos. 2012 Oct;40(10):1869-77. doi: 10.1124/dmd.112.045872. Epub 2012 Jun 27. Drug Metab Dispos. 2012. PMID: 22745334
-
Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.J Pharm Sci. 1978 May;67(5):703-4. doi: 10.1002/jps.2600670536. J Pharm Sci. 1978. PMID: 641815
-
Prediction of human pharmacokinetics--gut-wall metabolism.J Pharm Pharmacol. 2007 Oct;59(10):1335-43. doi: 10.1211/jpp.59.10.0002. J Pharm Pharmacol. 2007. PMID: 17910807 Review.
Cited by
-
Development of quantitative structure-pharmacokinetic relationships.Environ Health Perspect. 1985 Sep;61:295-306. doi: 10.1289/ehp.8561295. Environ Health Perspect. 1985. PMID: 3905378 Free PMC article. Review.